866-997-4948(US-Canada Toll Free)

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Venezuela

Published By :

GlobalData

Published Date : Sep 2017

Category :

Healthcare

No. of Pages : 145 Pages

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Venezuela

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Venezuela". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Venezula. It identifies the key trends in the countrys healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

Venezuelas population grew from 28.1 million in 2009 to 31 million in 2016. The value of the pharmaceuticals market increased from $5.7 billion in 2009 to $14.4 billion in 2016 at a Compound Annual Growth Rate (CAGR) of 14.1%, and this value is expected to increase further to $27.8 billion in 2021. However, the current political and economic landscape may negatively affect the growth of the pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Venezuela, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Bayer, Abbott, Sanofi, Novartis and Merck & Co.
- An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the countrys healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the countrys political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Venezuelan healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Venezuelas healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Venezuelas healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Executive Summary 8
3 Introduction 12
3.1 GlobalData Report Guidance 12
4 Overview of Pharmaceutical and Medical Device Markets 13
4.1 Pharmaceutical Market 13
4.1.1 Market Overview 13
4.1.2 Pharmaceutical Exports and Imports 15
4.1.3 Supply Channels 17
4.1.4 Market Segments 17
4.1.5 Overview of Top Five Disease Areas 19
4.1.6 Major Players 20
4.2 Medical Device Market 49
4.2.1 Market Overview 49
4.3 Market Drivers and Barriers 50
4.3.1 Drivers 50
4.3.2 Barriers 50
5 Market Access 52
5.1 Overview of Healthcare system 52
5.2 Reimbursement and Payer Landscape 54
5.2.1 Overview of Insurance Providers 56
5.2.2 Patient Share in Healthcare Expenditure 58
5.2.3 Price Trends in the Healthcare Sector 59
5.2.4 Pricing Policies 60
5.3 Regulatory Landscape 60
5.3.1 Overview of Regulatory Agencies 60
5.3.2 Market Authorization Procedure for Pharmaceutical Products 61
5.3.3 New Medical Device Approval Process 63
5.3.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 63
5.3.5 Intellectual Property Rights 64
5.3.6 Clinical Trial Regulations 70
5.3.7 Pharmacy Regulations 72
5.3.8 Labeling and Packaging Regulations 73
6 Country Analysis 76
6.1 Political Environment 76
6.1.1 Political Structure 76
6.1.2 Current Political Environment 77
6.1.3 Healthcare Policy Initiatives 78
6.1.4 Economic Landscape 80
6.2 Economic Indicators 84
6.2.1 Gross Domestic Product 84
6.2.2 Gross National Income 88
6.2.3 Inflation 89
6.2.4 Currency Exchange Rate 91
6.2.5 Foreign Direct Investment 92
6.2.6 Foreign Exchange Reserves 93
6.2.7 Trade Balance 94
6.2.8 Government Structural Balance 96
6.2.9 Government Gross Debt 97
6.2.10 Major Industries 98
6.3 Demographics 100
6.3.1 Population 100
6.4 Healthcare Infrastructure 122
6.4.1 Healthcare Facilities 122
6.4.2 Healthcare Parameters 123
6.4.3 Environmental Health 124
6.5 Healthcare Expenditure 126
6.5.1 Overview 126
6.5.2 Share of Public and Private Sectors 127
6.5.3 Major Components of Healthcare Expenditure 128
6.5.4 Spending in Pharmaceutical R&D 128
6.6 Trade Associations 129
6.6.1 Venezuelan Chamber of Medicine 129
6.6.2 Chamber of Pharmaceutical Industry 129
6.6.3 Chamber of Non-prescription Medicines 129
6.6.4 Venezuelan Association of Distributors of Medical Equipment, Dental Laboratories and Related Products 129
6.6.5 Venezuelan Chamber of Pharmacy 129
7 Opportunities and Challenges 130
7.1 Opportunities 130
7.2 Challenges 130
8 Appendix 132
8.1 Abbreviations 132
8.2 Bibliography 135
8.3 Research Methodology 143
8.3.1 Coverage 144
8.3.2 Secondary Research 144
8.3.3 Forecasts 145
8.3.4 Expert Panel 145
8.4 Contact Us 145
8.5 Disclaimer 145

1.1 List of Tables
Table 1: Pharmaceutical Market, Venezuela, Revenue ($bn), 2009-2016 14
Table 2: Pharmaceutical Market, Venezuela, Revenue ($bn), 2017-2021 15
Table 3: Pharmaceutical Market, Venezuela, Exports and Imports ($bn), 2009-2016 16
Table 4: Pharmaceutical Market, Venezuela, Total Deaths (%), 2014 19
Table 5: Bayer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016 21
Table 6: Pharmaceutical Market,Bayer, Global, Late-Stage Pipeline, 2017 22
Table 7: Sanofi, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016 31
Table 8: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2017 31
Table 9: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016 35
Table 10: Pharmaceutical Market, Novartis, Planned Filings, 2017-2020 36
Table 11: Pharmaceutical Market, Merck & Co., Global, Late-Stage Pipeline, 2017 44
Table 12: Healthcare Expenditure, Venezuela, Out-of-Pocket Expenditure (%), 2009-2015 58
Table 13: Market Access, Venezuela, Change in Average Prices of Healthcare Services (%), 2009-2015 59
Table 14: Market Access, Venezuela, Patent Fees ($), 2015 66
Table 15: Economic Indicators, Venezuela, GDP per Capita ($), 2009-2016 84
Table 16: Economic Indicators, Venezuela, GDP per Capita ($), 2017-2021 85
Table 17: Economic Indicators, Venezuela, GDP Annual Growth (%), 2009-2016 86
Table 18: Economic Indicators, Venezuela, GDP Annual Growth (%), 2017-2021 87
Table 19: Economic Indicators, Venezuela, GNI per Capita ($), 2009-2016 88
Table 20: Economic Indicators, Venezuela, Consumer Price Index, 2009-2016 89
Table 21: Economic Indicators, Venezuela, Average Consumer Price Index Annual Change (%), 2009-2016 90
Table 22: Economic Indicators, Venezuela, Currency Exchange Rate ($/VEF), 2009-2016 91
Table 23: Economic Indicators, Venezuela, Foreign Direct Investment ($bn), 2009-2015 92
Table 24: Economic Indicators, Venezuela, Foreign Exchange Reserves ($bn), 2009-2016 93
Table 25: Economic Indicators, Venezuela, Imports of Goods and Services ($bn), 2009-2016 94
Table 26: Economic Indicators, Venezuela, Exports of Goods and Services ($bn), 2009-2016 95
Table 27: Economic Indicators, Venezuela, General Government Structural Balance ($bn), 2009-2016 96
Table 28: Economic Indicators, Venezuela, Government Gross Debt ($bn), 2009-2016 97
Table 29: Economic Indicators, Venezuela, Production Index of Major Industries (physical production), 2017 99
Table 30: Demographics, Venezuela, Population (million), 2009-2016 100
Table 31: Demographics, Venezuela, Population (million), 2017-2021 101
Table 32: Demographics, Venezuela, Urban-Rural Population Share (%), 2009-2016 102
Table 33: Demographics, Venezuela, Urban-Rural Population Share (%), 2017-2021 103
Table 34: Demographics, Venezuela, Population Distribution by Age Group (%), 2009-2016 104
Table 35: Demographics, Venezuela, Population Distribution by Age Group (%), 2017-2021 105
Table 36: Demographics, Venezuela, Births (per 1,000 population), 2009-2016 106
Table 37: Demographics, Venezuela, Mortality (per 1,000 Population), 2009-2016 107
Table 38: Demographics, Venezuela, Major Causes of Mortality (Number of deaths), 2015 109
Table 39: Demographics, Venezuela, Mortality Rate of Children Under Five (per 1,000 live births), 2009-2016 110
Table 40: Demographics, Venezuela, Immunization Rate (%), 2009-2016 111
Table 41: Demographics, Venezuela, Major Causes of Male Mortality (number of deaths), 2015 113
Table 42: Demographics, Venezuela, Major Causes of Female Mortality (per 100,000 population), 2014 114
Table 43: Demographics, Venezuela, Gender Ratio (M/F), 2009-2016 115
Table 44: Demographics, Venezuela, Life Expectancy at Birth (years), 2009-2016 116
Table 45: Demographics, Venezuela, Life Expectancy at Birth (years), 2017-2021 117
Table 46: Demographics, Venezuela, Gross Enrollment Ratio (%), 2009-2016 119
Table 47: Demographics, Venezuela, Unemployment Rate (%), 2009-2016 120
Table 48: Demographics, Venezuela, Disability-Adjusted Life Years by Major Disease (000), 2015 121
Table 49: Healthcare Infrastructure, Venezuela, Hospitals, 2008-2013 123
Table 50: Healthcare Infrastructure, Venezuela, Doctors (per 1,000 population), 2009-2016 124
Table 51: Healthcare Infrastructure, Venezuela, PM2.5 (g per m), 2009-2016 125
Table 52: Healthcare Infrastructure, Venezuela, CO2 Emissions (metric tons per capita), 2009-2016 125
Table 53: Healthcare Infrastructure, Venezuela, Healthcare Expenditure as Percentage of GDP (%), 2009-2016 126
Table 54: Healthcare Infrastructure, Venezuela, Public-Private Share of Expenditure (%), 2009-2016 127
Table 55: Healthcare Infrastructure, Venezuela, Major Components of Healthcare Expenditure (%), 2014 128

1.2 List of Figures
Figure 1: Pharmaceutical Market, Venezuela, Revenue ($bn), 2009-2021 9
Figure 2: Country Profile, Venezuela, 2017 11
Figure 3: Pharmaceutical Market, Venezuela, Revenue ($bn), 2009-2016 14
Figure 4: Pharmaceutical Market, Venezuela, Revenue ($bn), 2017-2021 15
Figure 5: Pharmaceutical Market, Venezuela, Exports and Imports ($bn), 2009-2016 16
Figure 6: Pharmaceutical Market, Venezuela, Total Deaths (%), 2014 19
Figure 7: Healthcare Market, Venezuela, Drivers and Barriers, 2017 51
Figure 8: Market Access, Venezuela, Health System, 2017 54
Figure 9: Healthcare Expenditure, Venezuela, Out-of-Pocket Expenditure (%), 2009-2015 58
Figure 10: Market Access, Venezuela, Change in Average Prices of Healthcare Services (%), 2009-2015 59
Figure 11: Market Access, Venezuela, Drug Approval Process, 2016 62
Figure 12: Market Access, Venezuela, Patent Process, 2016 66
Figure 13: Market Access, Venezuela, Trademark Process, 2016 69
Figure 14: Market Access, Venezuela, Clinical Trial Approval Process, 2016 71
Figure 15: Economic Indicators, Venezuela, GDP per Capita ($), 2009-2016 84
Figure 16: Economic Indicators, Venezuela, GDP per Capita ($), 2017-2021 85
Figure 17: Economic Indicators, Venezuela, GDP Annual Growth (%), 2009-2016 86
Figure 18: Economic Indicators, Venezuela, GDP Annual Growth (%), 2017-2021 87
Figure 19: Economic Indicators, Venezuela, GNI per Capita ($), 2009-2016 88
Figure 20: Economic Indicators, Venezuela, Consumer Price Index, 2009-2016 89
Figure 21: Economic Indicators, Venezuela, Average Consumer Price Index, Annual Change (%), 2009-2016 90
Figure 22: Economic Indicators, Venezuela, Currency Exchange Rate ($/VEF), 2009-2016 91
Figure 23: Economic Indicators, Venezuela, Foreign Direct Investment ($bn), 2009-2015 92
Figure 24: Economic Indicators, Venezuela, Foreign Exchange Reserves ($bn), 2009-2016 93
Figure 25: Economic Indicators, Venezuela, Imports of Goods and Services ($bn), 2009-2016 94
Figure 26: Economic Indicators, Venezuela, Exports of Goods and Services ($bn), 2009-2016 95
Figure 27: Economic Indicators, Venezuela, Government Structural Balance ($bn), 2009-2016 96
Figure 28: Economic Indicators, Venezuela, Government Gross Debt ($bn), 2009-2016 97
Figure 29: Economic Indicators, Venezuela, Production Index of Major Industries (physical production), 2017 98
Figure 30: Demographics, Venezuela, Population (million), 2009-2016 100
Figure 31: Demographics, Venezuela, Population (million), 2017-2021 101
Figure 32: Demographics, Venezuela, Urban-Rural Population Share (%), 2009-2016 102
Figure 33: Demographics, Venezuela, Urban-Rural Population Share (%), 2017-2021 103
Figure 34: Demographics, Venezuela, Population Distribution by Age Group (%), 2009-2016 104
Figure 35: Demographics, Venezuela, Population Distribution by Age Group (%), 2017-2021 105
Figure 36: Demographics, Venezuela, Births (per 1,000 population), 2009-2016 106
Figure 37: Demographics, Venezuela, Mortality (per 1,000 Population), 2009-2016 107
Figure 38: Demographics, Venezuela, Major Causes of Mortality (number of deaths), 2015 108
Figure 39: Demographics, Venezuela, Mortality Rate of Children Under Five (per 1,000 live births), 2009-2016 110
Figure 40: Demographics, Venezuela, Immunization Rate (%), 2009-2016 111
Figure 41: Demographics, Venezuela, Major Causes of Male Mortality (number of deaths), 2015 112
Figure 42: Demographics, Venezuela, Major Causes of Female Mortality (per 100,000 population), 2014 114
Figure 43: Demographics, Venezuela, Gender Ratio (M/F), 2009-2016 115
Figure 44: Demographics, Venezuela, Life Expectancy at Birth (years), 2009-2016 116
Figure 45: Demographics, Venezuela, Life Expectancy at Birth (years), 2017-2021 117
Figure 46: Demographics, Venezuela, Gross Enrollment Ratio (%), 2009-2016 118
Figure 47: Demographics, Venezuela, Unemployment Rate (%), 2009-2016 119
Figure 48: Demographics, Venezuela, Major Diseases, Disability-Adjusted Life Years by Major Disease (000s), 2015 121
Figure 49: Healthcare Infrastructure, Venezuela, Hospitals, 2008-2013 122
Figure 50: Healthcare Infrastructure, Venezuela, Doctors (per 1,000 population), 2009-2016 123
Figure 51: Healthcare Infrastructure, Venezuela, PM2.5 (g per m), 2009-2016 124
Figure 52: Healthcare Infrastructure, Venezuela, CO2 Emissions (metric tons per capita), 2009-2016 125
Figure 53: Healthcare Infrastructure, Venezuela, Healthcare Expenditure as Percentage of GDP (%), 2009-2016 126
Figure 54: Healthcare Infrastructure, Venezuela, Public-Private Share of Expenditure (%), 2009-2016 127
Figure 55: Healthcare Infrastructure, Venezuela, Major Components of Healthcare Expenditure (%), 2014 128
Figure 56: Healthcare Market, Venezuela, Opportunities and Challenges, 2017 131

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *